AYAlastair Younger

Alastair Younger

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Alastair Younger has a total of 165 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Development and Internal Validation of a Predictive Model for Clinically Meaningful AOS Improvement After Primary Total Ankle Arthroplasty

    by Carlos F. Albarrán, Marianne Koolen, Tudor Trache, Sultan K. Alharbi, Andrea Veljkovic, Oliver Gagne, Murray J. Penner, Alastair Younger, Kevin Wing

    Background: Ankle osteoarthritis is a condition that generates a level of disability comparable to that of heart failure, chronic kidney failure, and end-stage hip and knee arthritis. To date, no predictive model has been described to determine which patients will experience a more pronounced improvement in patient-reported disability following total ankle replacement. Methods: In this prospective cohort study, we included all patients between 2003 and 2023 who after joint decision making with their surgeon elected to undergo a total ankle replacement. Patients undergoing primary ankle fusion, revision total ankle replacement, with a history of previous ankle infection or Charcot neuroarthropathy, and those who declined to participate in the registry were excluded. A total ankle arthroplasty was considered to have a good response if patients showed a difference greater or equal than 28 points between the pre-operative and the 1-2-year AOS score. A multivariable logistic regression using a stepwise method was performed, adding or removing variables, and analyzing demographic variables (age at the time of surgery, smoking status, diabetes, inflammatory pathology, and body mass index), prosthesis type (Infinity, InBone II, InVision, Agility, Hintegra, Mobility, Zimmer, and STAR), etiology, and the AOS at the time of enrollment. As variables were added or removed, the model’s Akaike information criterion was compared, ultimately keeping the most parsimonious version. After model selection, overfitting was evaluated using a bootstrapping method with 1000 replications, and finally, the goodness of fit was assessed with the Hosmer-Lemeshow test. Results: A total of 631 total ankle replacements were included. The average age at the time of surgery was 64.96 ± 9.7 years. The most frequently used total ankle replacement was Hintegra (n = 159), followed by Infinity (n = 151), Zimmer (n = 127), and Agility (n = 78). The variables included in the model were the AOS at the time of enrollment (OR 1.06, P < .01, 95% CI 1.05-1.08) and instability etiology (OR 5.1, P < .01, 95% CI 1.69-15.26). The AUC was 0.76, and when compared using the bootstrapping method, no differences were found, indicating that the model did not show overfitting. Finally, the Hosmer-Lemeshow test showed that calibration was satisfactory. Conclusion: Higher baseline disability and instability-related etiology were associated with increased likelihood of clinically meaningful improvement after TAR. This internally validated model may assist preoperative counseling and shared decision making. A baseline AOS score above 63 was associated with a high probability of clinically meaningful improvement. Level of Evidence: Level II, prospective cohort study.

  • Outcomes of Laterally Inserted Trabecular Metal Total Ankle Arthroplasty Comparing Cemented and Cementless Rail Fixation: A Prospective, Longitudinal Study

    by Alastair S. E. Younger, Jason Cholewa, J. Kent Ellington, Eric Giza, Theodor Patsalis, Fabian Krause, Federico G. Usuelli

    Background: This study investigated performance and safety differences between cemented and cementless fixation of trabecular metal total ankle arthroplasty (TAA) using a lateral transfibular approach. Methods: This nonrandomized, multicenter, prospective study included 59 cemented and 61 cementless TAA patients with mean follow-ups of 7.2 years (cemented) and 6.2 years (cementless). All cemented ankles were performed in North America; cementless fixation was performed in Europe. Implant survival (revision of tibial or talar implant for any reason) was the primary outcome. Secondary outcomes were radiographic measures and range of motion. Tertiary outcomes included American Orthopaedic Foot & Ankle Society (AOFAS) ankle-hindfoot score, Ankle Osteoarthritis Scale (AOS), and EuroQol 5-Dimension 5-Level (EQ-5D-5L). Results: At average 7 years’ combined follow-up, there were no significant differences ( P = .08) in survival between cemented (100%) and cementless (94.88%, 95% CI 84.94%-98.32%) fixation. More mid- and hind-foot fusions were performed in the cemented (n = 16) vs cementless cohort (n = 1, P < .05). Plantarflexion was similar between the cohorts through 7 years postoperative. Dorsiflexion was significantly greater in the cementless cohort from 6 weeks through 5 years postoperative. At 6 weeks postoperative, AOFAS, AOS pain, AOS disability, and EQ-5D-5L scores were significantly better in the cementless cohort ( P < .05). AOS disability and EQ-5D-5L scores remained better in the cementless cohort through 2 years and 1 year postoperative, respectively. Outcomes were similar between the groups at later time points. Postoperative patient satisfaction rates were similar for the groups: 95.9% (6 weeks), 90.0% (6 months), and 91.3% (1 year). Conclusion: TAA using a trabecular metal ankle implant with a transfibular approach was associated with excellent survival regardless of fixation. Greater improvements in function, pain, range of motion, and quality of life 6 weeks postoperative suggest faster recovery with cementless fixation; however, this may reflect an increased number of additional procedures performed in the cemented cohort.


  • Open Access

    Foot and ankle minimally invasive surgery what’s up?

    by Alastair Younger

    Minimally invasive surgery has become much more prevalent in foot and ankle surgery. The rate of publication has increased dramatically, and there is considerable interest in minimally invasive surgery. There are both proponents and critics, as well as benefits and potential complications. In this article, a review of the current literature on the evidence for and against minimally invasive surgery was conducted to present a balanced argument. I will also summarize my personal experience so that, upon reading this article, surgeons have a better understanding of why I have made this change and continue to evaluate outcomes, risks, and benefits. Level of evidence I; Therapeutic studies - investigating the results of treatment.

  • Anterior Approach Total Ankle Arthroplasty with Patient-Specific Cut Guides

    by Madeleine Willegger, Murray J. Penner, Lindsay Anderson, Oliver Gagné, Alastair Younger, Andrea Veljkovic

    Background: Over the last 30 years, total ankle arthroplasty (TAA) has become a viable surgical option for end-stage ankle arthritis 1,2 . The aim of TAA is to relieve pain and preserve ankle joint range of motion, which, by definition, shields adjacent joints 3–6 . Alignment is essential for the longevity and survival of TAA, since malalignment of TAA components can cause abnormal loading patterns with subsequent polyethylene wear and early implant failure 7–12 . Therefore, patient-specific instrumentation with higher accuracy of tibial and talar component placement and shorter operative times has major advantages in TAA 13 . This present video article describes the use of CT-based patient-specific instrumentation for TAA implantation. Description: On the basis of preoperative CT scans (PROPHECY Ankle CT Scan Protocol; Wright Medical Technology), a surgical plan is created with comments from an engineer that include the sizing and positioning of TAA implant components (INFINITY with ADAPTIS Technology Total Ankle System; Wright Medical Technology). This plan is reviewed by the surgeon with the opportunity for corrections and adjustments. After approval, the patient-specific cut guides for the TAA are manufactured. TAA with patient-specific cut guides is performed with the patient under general anesthesia, usually with a popliteal and saphenous nerve block for intraoperative and postoperative pain management. The patient is positioned supine with a bump underneath the ipsilateral hip in order to align the foot in neutral rotation. A thigh tourniquet is applied and set at 275 mmHg. Landmarks for the incision are outlined on the skin and the leg is exsanguinated. An anterior approach with a standard central incision is made, creating full-thickness skin flaps medially and laterally. Dissection of the superficial peroneal nerve (SPN) branches should be avoided. The interval between the tibialis anterior tendon and the extensor hallucis longus tendon is entered, and the neurovascular bundle with the deep peroneal nerve (DPN) and the anterior tibial artery is protected and retracted laterally. Hohmann retractors are placed medial and lateral, taking care not to place too much tension on the skin. The anterior distal tibia and the dorsal talus are cleaned of all soft tissues, periosteum, and possible residual cartilage in order to obtain a good cortical read. The patient-specific cut guides (INFINITY PROPHECY, Total Ankle System; Wright Medical Technology) are placed first at the distal tibia and are fixed with temporary pins. Anteroposterior (AP) and lateral fluoroscopic images are made in order to confirm alignment of the tibial alignment guide, which should be neutral relative to the mechanical tibial axis. Once the position is appropriate, the guide is switched to the tibial resection guide, followed by tibial resection with use of an oscillating saw. The patient-specific talar alignment guide is then placed and fixed with pins. Pins are placed through the anterior pin holes, and the guide is switched to the cut guide. AP and lateral fluoroscopic images are made in order to check the talar resection. The talar resection guide will not necessarily be the same size as that used during the tibial resection. A lamina spreader is inserted, and ligament balancing is performed. The posterior capsule can be released at this time if it is tight. Next, the tibial trial is placed over the pins and the appropriate AP positioning of the tibial component is determined and checked on lateral fluoroscopy. Once the position is set, the broaches for the pegs are inserted and tapped in with a mallet. A talar dome trial is inserted together with a polyethylene insert trial, which should engage with the tibial trial. The talar component alignment and rotation are checked clinically as well as under fluoroscopy. Under axial compression and ankle dorsiflexion and plantarflexion, the talar component will rotate into its anatomic position. Two 2.4-mm Steinmann pins are utilized to fix the talar trial component temporarily. The talar resection guide is placed. Temporary fixation screws are placed and tightened by hand. The chamfer cuts are made with an oscillating saw. The talar pilot guide is placed, and the talar reamer is utilized to plunge cut in order to prepare the talar surface. Once this is finished, the pins and the guides are removed, and the residual bone is removed with use of a rongeur. Irrigation is performed with a saline solution. The definitive components are opened, and the tibial component is implanted first and impacted. The tibial pegs must be in the prepared holes. Verification that the component is fully seated is confirmed under lateral fluoroscopic imaging. The talar component is then inserted and impacted. A trial polyethylene liner is inserted, and varus and valgus stress and range of motion are tested. The liner size is then determined. The liner insert guide rail is attached, and the liner is slid into the joint space. With a gentle tap on the liner with the impactor, the fixed-bearing mechanism is locked. Finally, osteophytes, which could block the range of motion, are removed. Final fluoroscopic images are made. After copious irrigation, the wound is closed in layers. Sterile dressings are placed over the wounds, and a padded tri-slab splint is fashioned to immobilize the limb in neutral ankle dorsiflexion. Alternatives: Nonoperative alternatives include shoe wear modification, the use of NSAIDs, physiotherapy, physical therapy, the use of an orthosis, ankle bracing, and intra-articular injections. Operative alternatives include joint-preserving osteotomies and ankle arthrodesis (AA) (arthroscopic or open). Rationale: In comparison to ankle arthrodesis, prospective and retrospective cross-sectional studies showed that several patient-reported outcomes were greater after TAA than after AA, without a significant difference in revision rates and complications 14–17 . The anterior approach is the most commonly used approach for TAA and gives the surgeon the best exposure of the ankle joint. Varus and valgus deformity of >15° is a relative contraindication, and >20° deformity is an absolute contraindication for TAA 18 . If these deformities are not addressed appropriately, long-term survival may be impaired. Multiple studies have shown that malalignment of TAA components can induce high joint contact pressures and therefore lead to early implant failure 7–12 . Patient-specific instrumentation in TAA may improve accuracy of implant positioning. Performing TAA using patient-specific cut guides enables the surgeon to plan intra-articular deformity correction, template bone resection, and implant alignment and sizing according to the patient’s unique anatomy. Cut guides are based on preoperative CT scans and are single-use instrumentation guides to mark bone cuts for tibial and talar component positioning. Minimal bony resection to preserve the bone stock for future possible revision surgeries is essential, especially in younger patients with end-stage ankle arthritis (< 55 years). Additionally, operative time and fluoroscopy time has been decreased compared with the traditional standard referencing guide technique in TAA 13 . Longer operative times have been shown to place patients at higher risk for wound complications in TAA 19 , which could be reduced by performing TAA with patient-specific cut guides. Expected Outcomes: Patients start weight-bearing at 2 weeks postoperatively, which is approximately 4 weeks earlier than patients who undergo ankle arthrodesis 17 . Patient expectations are more likely to be met by TAA than by ankle arthrodesis 20 . Gait analysis has shown that walking speed is faster after TAA compared with ankle arthrodesis. Hindfoot and forefoot sagittal motion is greater following TAA, and gait also more closely resembles the patient’s natural gait 21 . Analysis of prospective data showed that in the presence of complex deformity or adjacent joint arthritis, as determined by the Canadian Orthopaedic Foot and Ankle Society (COFAS) classification (COFAS 3 and 4 ankles), patient-reported outcomes were better in patients undergoing TAA compared with ankle arthrodesis. In cases of ankle arthritis without deformity, TAA yielded higher patient-reported outcome measures compared with open ankle arthrodesis. Nevertheless, patients who underwent TAA had a significantly higher rate of additional surgical procedures. TAA patients in general have also been shown to have higher reoperation rates, at around 6% to 7% within a 2-year follow-up window 15,17 . Long-term follow-up data on TAA have shown revision rates between 16% and 54%; however, these rates were for older implant designs, and these numbers might not be applicable for the implant utilized in the presently described technique 22,23 . The Infinity TAA has shown a revision rate of 3% after a 3-year follow-up study 24 . Infection rates after primary TAA have ranged from 1.4% to 2.4% 25 . Important Tips: Acronyms and Abbreviations: TAA = total ankle arthroplasty NSAID = nonsteroidal anti-inflammatory drug CT = computed tomography COFAS = Canadian Orthopaedic Foot and Ankle Society AA = ankle arthrodesis SPN = superficial peroneal nerve DPN = deep peroneal nerve ER = extensor retinaculum TA = tibialis anterior EHL = extensor hallucis longus AP = anteroposterior DVT = deep vein thrombosis


  • Navicular Stress Fractures of the Foot

    by Alastair Younger, Andrea Veljkovic, James Ryeburn

  • Navicular Stress Fractures of the Foot

    by Alastair Younger, Andrea Veljkovic, James Ryeburn

  • Open Access

    Granzyme B cleaves tenascin-C to release its C-terminal domain in rheumatoid arthritis

    by Alexandre Aubert, Amy Liu, Martin Kao, Jenna Goeres, Katlyn C. Richardson, Lorenz Nierves, Karen Jung, Layla Nabai, Hongyan Zhao, Gertraud Orend, et al.

    Rheumatoid arthritis (RA) is a common autoimmune disorder characterized by exacerbated joint inflammation. Despite the well-documented accumulation of the serine protease granzyme B (GzmB) in RA patient biospecimens, little is understood pertaining to its role in pathobiology. In the present study, tenascin-C (TNC) — a large, pro-inflammatory extracellular matrix glycoprotein — was identified as a substrate for GzmB in RA. GzmB cleaves TNC to generate 3 fragments in vitro: a 130 kDa fragment that remains anchored to the matrix and 2 solubilized fragments of 70 and 30 kDa. Mass spectrometry results suggested that the 30 kDa fragment contained the pro-inflammatory TNC C-terminal fibrinogen-like domain. In the synovial fluids of patients with RA, soluble levels of GzmB and TNC were significantly elevated compared with healthy controls. Further, immunoblotting revealed soluble 70 and 30 kDa TNC fragments in the synovial fluids of patients with RA, matching TNC fragment sizes generated by GzmB cleavage in vitro. Granzyme K (GzmK), another serine protease of the granzyme family, also cleaves TNC in vitro; however, the molecular weights of GzmK-generated TNC fragments did not correspond to TNC fragment sizes detected in patients. Our data support that GzmB, but not GzmK, contributes to RA through the cleavage of TNC.


  • Open Access

    A Novel Update on the Management of Müller-Weiss Disease: Presentation of a Treatment Algorithm

    by Chayanin Angthong, Alastair S.E. Younger, Bavornrit Chuckpaiwong, Thos Harnroongroj, Andrea Veljkovic

    Objective: Müller-Weiss disease (MWD) is a challenging condition involving the perinavicular region in the initial stages and subsequently the entire foot in the later stages. The goal of this article is to describe the pathomechanics, clinical evaluation, and nonoperative and operative treatment, including a treatment algorithm, based on current evidence and the combined authors’ experience. Design: We review the related articles and summarize the information about this condition. Results: A number of related articles reveal that the treatments should focus on the management of degenerative regions and deformity correction to restore normal foot alignment and provide pain relief. Conclusion: This systematic review proposes a treatment algorithm that is comprehensive and practical to apply for the management of MWD.


  • Open Access

    Patient Reported Outcomes Following Revision Ankle Arthrodesis for Ankle Fusion Non-Union

    by Madeleine Willegger, Andrea Veljkovic, Lucky Jeyaseelan, Sam Si-Hyeong Park, Dani Lowe, Alastair Younger, Kevin Wing, Murray Penner

    Category: Ankle Arthritis; Hindfoot Introduction/Purpose: Ankle arthrodesis (AA) has, for many years, been considered the gold standard procedure for the surgical treatment of end stage ankle arthritis. Non-union following AA surgery is a devastating complication which subsequently requires revision surgery. However, data on outcomes including patient reported outcome measures (PROMs) following revision ankle arthrodesis (RAA) after failed AA is lacking. The aim of this study is to assess the outcome of RAA for symptomatic non-union after AA including PROMs. Methods: Prospectively collected data from a multicenter database of ankle arthritis surgery was analyzed. Demographic data and PROMs including Ankle Osteoarthritis Scale (AOS) and Short Form-36 (SF-36) health survey were collected at regular intervals. Surgeries were performed by six fellowship-trained foot and ankle surgeons between January 2003 and July 2015. 336 primary AA cases were identified, of which 27 (8%) underwent revision for symptomatic AA non-union. Results: Mean follow-up of 27 AA non-union cases was 5.3 years (2-10). There were 16 (59%) males and 11 (41%) females, with a mean age of 62 years (44 - 81) and a mean BMI of 32 (26.5 – 45), respectively. At index AA, 12 (44%) cases were performed arthroscopically. Twenty-three (84%) AA non-union patients were actively smoking pre- and post-operatively, and 15 (56%) were diabetic. Overall union-rate following RAA was 85% (23/27). For RAA the pre-operative mean AOS score of 64.9 (38.8-81.5) improved to 49.1 (24.1-73) at latest follow-up. SF-36 PCS score improved from 27.2 (21.3 – 38.3) to 33.3 (19.1-54.2) and SF-36 MCS score improved from 41.2 (17.5-60.9) to 46.2 (29.3-65.9). Overall complication rate of RAA was 22%, with a re-operation rate of 15%. Conclusion: Revision ankle arthrodesis (RAA) for ankle fusion non-union resulted in a successful fusion of the ankle in 85% of patients with modest improvement in AOS and SF-36 scores. Indeed, even after successful RAA, patients report pain and disability levels comparable to that reported by primary AA patients pre-operatively. Additionally, complication and re-operation rates of RAA are high. This data emphasizes on the importance of achieving a primary fusion in AA. The presented patient reported outcomes may help the treating surgeon to counsel patients prior to RAA surgery to better set their expectations.